May 22 (Reuters) - Japan's Otsuka Pharmaceutical said on Wednesday it will stop development of its experimental drug to treat patients with agitation associated with Alzheimer's disease. (Reporting by Mariam Sunny in Bengaluru; Editing by Maju Samuel)